Jiangsu Lianhuan Pharmaceutical Co., Ltd. (SHA:600513)

SHA:600513 Revenue

Jiangsu Lianhuan Pharmaceutical had revenue of 810.63M CNY in the quarter ending March 31, 2026, with 29.14% growth. This brings the company's revenue in the last twelve months to 2.89B, up 28.10% year-over-year. In the year 2025, Jiangsu Lianhuan Pharmaceutical had annual revenue of 2.71B with 25.52% growth.

• Revenue (ttm): 2.89B
• Revenue Growth: +28.10%
• P/S Ratio: 1.57
• Revenue / Employee: 1.36M
• Employees: 2,131
• Market Cap: 4.54B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.71B	551.40M	25.52%
Dec 31, 2024	2.16B	-13.64M	-0.63%
Dec 31, 2023	2.17B	218.94M	11.20%
Dec 31, 2022	1.96B	309.34M	18.80%
Dec 31, 2021	1.65B	259.78M	18.74%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 2, 2026

Data Sources Report a data error